Clinical Trial Update: Lonafarnib With and Without Ritonavir in HDV (LOWR-1) [Phase 2]

View source ↗

Summary

Phase 2 trial update evaluating lonafarnib with and without ritonavir in chronic Hepatitis D infection has completed with results posted.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Hepatitis D

Drugs mentioned

• Lonafarnib (lonafarnib)
• Ritonavir (Ritonavir)

Snippet

Sponsor: Eiger BioPharmaceuticals | Conditions: Chronic Hepatitis D Infection | Phase 2 | Status: COMPLETED | Results posted: 2022-11-29